Snowden Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-20,654
Closed -$256K – 1144
2022
Q3
$256K Sell
20,654
-3,193
-13% -$55.8K 0.01% 954
2022
Q2
$468K Buy
23,847
+1,735
+8% +$41.1K 0.02% 661
2022
Q1
$576K Buy
22,112
+21,612
+4,322% +$576K 0.02% 580
2021
Q4
$14K Sell
500
-12,840
-96% -$399K ﹤0.01% 1424
2021
Q3
$425K Sell
13,340
-546
-4% -$18.3K 0.02% 577
2021
Q2
$482K Buy
13,886
+950
+7% +$31.3K 0.02% 561
2021
Q1
$381K Buy
+12,936
New +$398K 0.02% 556

Other funds holding ELAN

Snowden Capital Advisors's ELAN Position: Q4 2022 in Review

Snowden Capital Advisors sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 20,654 shares — an estimated $256K sold.

Snowden Capital Advisors first reported a position in ELAN in Q1 2021 and held it in 7 quarters. The position peaked at $576K in Q1 2022. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Snowden Capital Advisors reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 20,654 Elanco Animal Health shares in Q4 2022, an estimated $256K.
  • Snowden Capital Advisors first reported a position in Elanco Animal Health in Q1 2021 and held it in 7 quarters.
  • Snowden Capital Advisors's Elanco Animal Health position peaked at $576K in Q1 2022.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Snowden Capital Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.